A Heartbreaker at Medtronic

With a strong presence in the implantable cardioverter-defibrillator (ICD) market, the medical device maker Medtronic (NYSE: MDT  ) announced on Monday it would voluntarily suspend distribution of its Sprint Fidelis family of defibrillation leads due to the risk of lead fractures.

Reaction in the market was swift yesterday with Medtronic shares retreating more than 11% by the closing bell. This decision by Medtronic will likely heighten anxiety not only in the company's shareholders, but also in patients who have been implanted with these defibrillation leads. Medtronic has identified five patient deaths in which a Sprint Fidelis lead fracture may have been a possible or likely contributing factor. Patients with Medtronic pacemakers are not affected.

Its ICD business is not the company's only segment that has been met with adversity of late. Medtronic's coronary stent segment also nearly hit a snag when the FDA said that a study that compared the company's Endeavor drug-coated stent with Boston Scientific's (NYSE: BSX  ) competing drug-coated stent failed to meet a secondary goal. But last week, an FDA advisory committee recommended the Endeavor for conditional approval. Medtronic is battling to enter the U.S. drug-coated stent market alongside Boston Scientific and Johnson & Johnson (NYSE: JNJ  ) . 

Shares of Medtronic are now very close to the stock's 52-week low. The decision by the company to suspend its distribution of the potentially faulty Sprint Fidelis leads was crucial for the organization to maintain its overall integrity. Fortunately, the company has a fairly diverse product portfolio and should be able to bounce back from this episode over time.   

For related Foolishness check out:

Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 538557, ~/Articles/ArticleHandler.aspx, 10/28/2016 10:43:06 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,203.65 33.97 0.19%
S&P 500 2,136.59 3.55 0.17%
NASD 5,215.62 -0.35 -0.01%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/28/2016 10:27 AM
MDT $81.72 Up +0.59 +0.73%
Medtronic CAPS Rating: *****
BSX $22.21 Up +0.72 +3.33%
Boston Scientific CAPS Rating: ***
JNJ $115.53 Down -0.17 -0.15%
Johnson and Johnso… CAPS Rating: *****